Showing results (111-120 of 134) with videos related to
Sort By:
Pageof 14
Microbiome|June 26, 2016
MetaPro-IQ: a universal metaproteomic approach to studying human and mouse gut microbiotaXu Zhang, Zhibin Ning, Janice Mayne, et al.Nature Communications|June 10, 2023
Revealing proteome-level functional redundancy in the human gut microbiome using ultra-deep metaproteomicsLeyuan Li, Tong Wang, Zhibin Ning, et al.The American Journal of Gastroenterology|March 14, 2018
Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitisShelley A Deeke, Amanda E Starr, Zhibin Ning, et al.Gut|May 25, 2016
Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UCAmanda E Starr, Shelley A Deeke, Zhibin Ning, et al.Microbiome|July 9, 2018
Disruption of maternal gut microbiota during gestation alters offspring microbiota and immunityDonald D Nyangahu, Katie S Lennard, Bryan P Brown, et al.Nature Communications|July 22, 2018
Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel diseaseXu Zhang, Shelley A Deeke, Zhibin Ning, et al.Antioxidants (Basel, Switzerland)|April 14, 2025
Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of ActionFrancis Feldman, Mireille Koudoufio, Alain Théophile Sané, et al.Biomedicines|September 28, 2021
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic PerturbationsMathilde Foisy Sauvé, Francis Feldman, Mireille Koudoufio, et al.BMC Microbiology|July 22, 2020
Examining the relationship between maternal body size, gestational glucose tolerance status, mode of delivery and ethnicity on human milk microbiota at three months post-partumLauren LeMay-Nedjelski, James Butcher, Sylvia H Ley, et al.Antioxidants (Basel, Switzerland)|January 21, 2023
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated DisordersFrancis Feldman, Mireille Koudoufio, Ramy El-Jalbout, et al.Pageof 14